Mechanism of anti-β-adrenoceptor antibody mediated myocardial damage in dilated cardiomyopathy
Liao Yuhua , Cheng Longxian , Tu Yuanshu , Zhang Jinzhi , Dong Jihua , Li Shuli , Tian Yuan , Peng Youhong
Current Medical Science ›› 1997, Vol. 17 ›› Issue (1) : 5 -8.
Mechanism of anti-β-adrenoceptor antibody mediated myocardial damage in dilated cardiomyopathy
Antibodies against β1-adrenoceptor can be detected in serum of patients with dilated cardiomyopathy (DCM), which have β-agonist-like activity, and induce a positive chronotropic effect on cardiac myocytes by its persistence at full strength. Effects of the antibodies against β-adrenoceptor from sera of patients with DCM on myocardial cytotoxicity and cytoplasmic free Ca2+-concentration ([Ca2+]i) were observed in the cultured single layer SD rat ventricular cells by using the cytotoxicity assay and fluorescent Ca2+- indicator fura-2/AM. The positive sera of the anti-β-adrenoceptor antibodies from patients with DCM markedly enhanced myocardial [Ca2+]i. Betaloc, a βi-receptor blocker, might inhibit the increase of the antibody-mediated myocardial [Ca2+]i, and the sera from healthy donors had no effect on myocardial [Ca2+]i. Our results suggest that the anti-β-adrenoceptor antibody might increase myocardial [Ca2+]i and result in myocardial damage. The antibodies might activate receptor-gating [Ca2+]-channel, thereby causing myocardial [Ca2+]i rise and calcium overload. Early use of betaloc is recommended in the treatment of dilated cardiomyopathy.
antibodies / β-adrenoceptor / cytoplasmic free calcium / fura-2/AM / dilated cardiomyopathy
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
1994,74:375 |
| [7] |
ADP/ATP 1995, 11:211 |
| [8] |
ADP/ATP, 1995, 11:335 |
| [9] |
|
| [10] |
|
/
| 〈 |
|
〉 |